Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

SCM Pharma

SCM Pharma is a contract development & manufacturing organisation (CDMO) that develops and makes novel, difficult and dangerous drugs on behalf of our clients. Our formulation development, cGMP manufacturing and aseptic processing services include the sterile filling of liquids, gels and powders (including flammable products) into a range of final dosage forms including ampoules, vials, cartridges, syringes and bottles. So if you’re a pharmaceutical, biotech, medical device or healthcare institution in need of formulation development, clinical manufacturing or contract filling involving a complex product or process – let’s talk.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

SCM Pharma
Unit 6 Regents Drive, Low Prudhoe Industrial Estate, Prudhoe, Northumberland, NE42 6PX, United Kingdom
+44(0) 1661 833 693
Contact SCM Pharma
Website

 Latest Content from PMHub 

Lucid Group starts new trend for CME in IBD education

Press Releases | October 1, 2015 | Lucid Group Communications Limited

A tailored educational event in IBD

Lucid Group’s new website is launched!

Press Releases | October 1, 2015 | Lucid Group Communications Limited

Lucid Group unveil new website...

Bigger than brand: Portfolio Positioning for Pharma

White Papers and Resources | September 29, 2015 | Blue Latitude Health

Senior Consultant Jenna Earl talks us through the three most important things to understand about portfolio positioning in pharma.

Tackling biosimilars – how to handle the threat to Pharma brands

White Papers and Resources | September 24, 2015 | Blue Latitude Health

Strategy Consultant Mark Assenti outlines three key points for developing a strategy to tackle the threat to Pharma brands from biosimilars.

Is Technology Harming Your Brain?

White Papers and Resources | September 22, 2015 | Say Communications

Is technology harming your brain? Saycomms healthcare PR team confronts different opinions on how technology affects memories and attention span.

Machine-made humans: a spooky prospect

White Papers and Resources | September 22, 2015 | Say Communications

The healthcare team at Saycomms PR asks if major advances in 3D printing and bioprinting could lead to machine-made humans.

Patient-Centricity: Improving the model with patient journeys

White Papers and Resources | September 15, 2015 | Blue Latitude Health

Head of Customer Experience Elisa del Galdo takes us through a better way to look at patient-centricity: with the patient's journey at the centre.

Four Communications acquires Healthcare specialist MSA Media

Press Releases | September 9, 2015 | Four Agency Worldwide

Independent integrated communications agency, Four Communications Group has acquired 100 per cent of market-leading healthcare media planning & buying agency MSA Media.

The vitamin D deficiency: should we act?

White Papers and Resources | September 2, 2015 | Say Communications

Healthcare PR agency Say Communications analyses whether headlines are able to trigger a behavioural change with regards to the vitamin D deficiency issue.

Is obesity the new smoking?

White Papers and Resources | September 2, 2015 | Say Communications

Is obesity the new smoking? The healthcare PR team at Say communications analyses the question posed by NHS Chief executive Simon Stevens.